Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study (Aug, 10.1007/s40120-023-00533-1, 2023)Jason Aldred,Eric Freire-Alvarez, Alexander V. Amelin,Angelo Antonini,Bruno Bergmans,Filip Bergquist,Manon Bouchard,Kumar Budur,Camille Carroll,K. Ray Chaudhuri,Susan R. Criswell,Erik H. Danielsen,Florin Gandor,Jia Jia,Thomas E. Kimber,Hideki Mochizuki,Weining Z. Robieson, Amy M. Spiegel,David G. Standaert, Saritha Talapala,Maurizio F. Facheris,Victor S. C. FungNEUROLOGY AND THERAPY（2023）引用 0|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
